Please wait a minute...
文章检索
预防医学  2025, Vol. 37 Issue (5): 465-470    DOI: 10.19485/j.cnki.issn2096-5087.2025.05.007
  论著 本期目录 | 过刊浏览 | 高级检索 |
肺炎住院患者多重耐药菌感染的预测模型研究
白瑞盈1, 生海燕2
1.蚌埠医科大学研究生院,安徽 蚌埠 233030;
2.蚌埠医科大学第二附属医院,安徽 蚌埠 233000
A prediction model of multidrug resistant bacterial for inpatients with pneumonia
BAI Ruiying1, SHENG Haiyan2
1. Graduate School, Bengbu Medical University, Bengbu, Anhui 233030, China;
2. The Second Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui 233000, China
全文: PDF(1086 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 构建肺炎住院患者多重耐药菌感染预测模型,为多重耐药菌感染早期识别及干预提供依据。方法 选择2022年10月—2024年6月在蚌埠医科大学第二附属医院治疗的肺炎住院患者为研究对象,收集患者基本信息和临床资料;采集呼吸道分泌物做病原学培养和药物敏感性试验;采用LASSO回归和多因素logistic回归模型筛选预测因子,建立肺炎住院患者多重耐药菌感染的预测模型;采用受试者操作特征(ROC)曲线、校准曲线和决策曲线评估模型的预测效果。结果 纳入肺炎住院患者368例,其中男性215例,占58.42%;女性153例,占41.58%。年龄MQR)为71.00(20.00)岁。检出多重耐药菌感染168例,检出率为45.65%。多因素logistic回归分析结果显示,长期卧床(OR=2.699,95%CI:1.120~6.504)、近30 d内使用抗生素(OR=8.623,95%CI:2.949~25.216)、呼吸衰竭(OR=2.407,95%CI:1.058~5.478)、重症监护病房治疗(OR=3.995,95%CI:1.313~12.161)和低蛋白血症(OR=2.129,95%CI:1.012~4.480)是肺炎住院患者多重耐药菌感染的预测因子。建立的多重耐药菌感染预测模型ROC曲线下面积为0.909(95%CI:0.879~0.939);校准曲线趋近于标准曲线,预测值与实测值高度吻合;决策曲线显示概率阈值为0.27~0.99时,预测多重耐药菌感染风险的临床净收益较高。结论 本研究构建的多重耐药菌感染预测模型对肺炎住院患者多重耐药菌感染具有较好的预测价值。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
白瑞盈
生海燕
关键词 肺炎住院患者多重耐药菌影响因素预测模型    
AbstractObjective To create a prediction model of multidrug resistant bacterial infections for inpatients with pneumonia, so as to provide the reference for the early identification and intervention of multidrug resistant bacterial infections. Methods The inpatients with pneumonia in the Second Affiliated Hospital of Bengbu Medical University from October 2022 to June 2024 were selected as the research subjects. Basic information and clinical data of the patients were collected. Respiratory secretions were collected for etiological culture and drug sensitivity tests to analyze the infection situation of multidrug resistant bacteria. LASSO regression and a multivariable logistic regression model were used to screen predictive factors and establish a predictive model of multidrug resistant bacterial infections for inpatients with pneumonia. The predictive effect of the model was assessed by receiver operating characteristic (ROC) curve, calibration curve, and decision curve. Results A total of 368 inpatients with pneumonia were recruited, including 215 males (58.42%) and 153 females (41.58%). The median age was 71.00 (interquartile range, 20.00) years. There were 168 cases of multidrug resistant bacterial infections detected, with a detection rate of 45.65%. The multivariable logistic regression analysis showed that long-term bedridden patients (OR=2.699, 95%CI: 1.120-6.504), use of antibiotics within 30 days (OR=8.623, 95%CI: 2.949-25.216), respiratory failure (OR=2.407, 95%CI: 1.058-5.478), intensive care unit treatment (OR=3.995, 95%CI: 1.313-12.161), and hypoproteinemia (OR=2.129, 95%CI: 1.012-4.480) were predict factors of multidrug resistant bacterial infections for inpatients with pneumonia. The area under the ROC curve of the established multidrug resistant bacterial infection prediction model was 0.909 (95%CI: 0.879-0.939). The calibration curve after repeated sampling calibration approached the standard curve, and the predicted values were highly consistent with the measured values. The decision curve showed that when the probability threshold is 0.27-0.99, the clinical net benefit for predicting the risk of multidrug resistant bacterial infection is relatively high. Conclusion The prediction model of multidrug resistant bacteria infection constructed has a good predictive value for multidrug resistant bacterial infection among inpatients with pneumonia.
Key wordspneumonia    inpatient    multidrug resistant bacteria    influencing factor    prediction model
收稿日期: 2024-11-25      修回日期: 2025-04-07     
中图分类号:  R563  
基金资助:蚌埠医学院2023年度研究生科研创新计划自然科学项目(Byycx23143)
作者简介: 白瑞盈,硕士研究生在读,呼吸系病专业
通信作者: 生海燕,E-mail:24371542@qq.com   
引用本文:   
白瑞盈, 生海燕. 肺炎住院患者多重耐药菌感染的预测模型研究[J]. 预防医学, 2025, 37(5): 465-470.
BAI Ruiying, SHENG Haiyan. A prediction model of multidrug resistant bacterial for inpatients with pneumonia. Preventive Medicine, 2025, 37(5): 465-470.
链接本文:  
https://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2025.05.007      或      https://www.zjyfyxzz.com/CN/Y2025/V37/I5/465
[1] 黄勋,邓子德,倪语星,等.多重耐药菌医院感染预防与控制中国专家共识[J].中国感染控制杂志,2015,14(1):1-9.
HUANG X,DENG Z D,NI Y X,et al.Chinese experts' consensus on prevention and control of multidrug resistance organism healthcare-associated infection[J].Chin J Infect Control,2015,14(1):1-9.(in Chinese)
[2] BONNET M,ECKERT C,TOURNEBIZE R,et al.Decolonization of asymptomatic carriage of multi-drug resistant bacteria by bacteriophages?[J/OL].Front Microbiol,2023,14[2025-04-07].https://doi.org/10.3389/fmicb.2023.1266416.
[3] 王丹,朱丹,夏敏,等.预防综合ICU多重耐药菌医院感染的成本效益分析[J].中国感染控制杂志,2021,20(12):1119-1125.
WANG D,ZHU D,XIA M,et al.Cost-benefit of prevention of multidrug-resistant organism healthcare-associated infection in a general intensive care unit[J].Chin J Infect Control,2021,20(12):1119-1125.(in Chinese)
[4] 黄琦,杨天富,姜成安,等.基于证据的强化培训与监测管理对医院多重耐药菌感染防控的影响研究[J].现代医院,2025,25(1):140-142,147.
HUANG Q,YANG T F,JIANG C A,et al.Study on the impact of evidence-based reinforcement training and monitoring management on the prevention and control of hospital-acquired multidrug-resistant organism infections[J].Mod Hosp J,2025,25(1):140-142,147.(in Chinese)
[5] 段滢,胡明霞.某院多重耐药菌医院感染的流行病学分析[J].抗感染药学,2024,21(7):714-717.
DUAN Y,HU M X.Epidemiological analysis of healthcare-associated infections caused by multidrug-resistant organisms in a hospital[J].Ant iInfect Pharm,2024,21(7):714-717.(in Chinese)
[6] 刘平香,沈湘波,欧政.某院高龄肺部感染患者多重耐药菌的检出情况及其危险因素分析[J].抗感染药学,2023,20(11):1199-1202.
LIU P X,SHEN X B,OU Z.Analysis of the detection of multidrug-resistant bacteria and their risk factors in elderly patients with lung infection in a hospital[J].Anti Infect Pharm,2023,20(11):1199-1202.(in Chinese)
[7] 于翠香,王西艳.《中国成人医院获得性肺炎与呼吸机相关性肺炎诊断和治疗指南(2018年版)》解读[J].中国医刊,2021,56(9):951-953.
YU C X,WANG X Y.Interpretation of the Guidelines for the Diagnosis and Treatment of ventilator-Associated Pneumonia in Adult Hospitals of China(2018)[J].Chin J Med,2021,56(9):951-953.(in Chinese)
[8] 曹季平. 基于《社区获得性肺炎诊断和治疗指南(2016版)》对医院成人CAP患者抗菌药物使用的相关因素分析[J].抗感染药学,2020,17(3):323-327.
CAO J P.Analysis of relevant factor of antibiotic medication in adult patients with CAP in hospital based on Guidelines of CAP 2016 Edition[J].Anti Infect Pharm,2020,17(3):323-327.(in Chinese)
[9] Clinical and Laboratory Standards Institute.Performance standards.for antimicrobial susceptibility testing[EB/OL].[2025-04-07]https://clsi.org/search/?term=Performance+standards+for+antimicrobial+susceptibility+testing.31sted.CLSI+supplement+M10&tab=products-services.
[10] EL MEKES A,ZAHLANE K,AIT SAID L,et al.The clinical and epidemiological risk factors of infections due to multi-drug resistant bacteria in an adult intensive care unit of University Hospital Center in Marrakesh-Morocco[J].J Infect Public Health,2020,13(4):637-643.
[11] CHINTALAPUDI N,ANGELONI U,BATTINENI G,et al.LASSO regression modeling on prediction of medical terms among seafarers' health documents using tidy text mining[J].Bioengineering(Basel),2022,9(3):124-137.
[12] NTUMY M Y,TETTEH J,AGUADZE S,et al.Predictive model for genital tract infections among men and women in Ghana:an application of LASSO penalized cross-validation regression model[J/OL].Epidemiol Infect,2024,152[2025-04-07].https://doi.org/10.1017/S0950268824001444.
[13] 孙卫锋,吕锐,胡喜荣,等.老年住院脑卒中患者医院获得性肺炎病原菌分布及耐药性分析[J].预防医学,2021,33(12):1256-1259.
SUN W F,LYU R,HU X R,et al.Distribution and drug resistance of hospital-acquired pneumonia pathogens in elderly stroke patients[J].China Prev Med J,2021,33(12):1256-1259.(in Chinese)
[14] GOLLI A L,CRISTEA O M,ZLATIAN O,et al.Prevalence of multidrug-resistant pathogens causing bloodstream infections in an intensive care unit[J].Infect Drug Resist,2022,15:5981-5992.
[15] 张静,李雨珂,王臻,等.重症肺炎患者多药耐药菌感染的病原学及影响因素模型构建[J].中华医院感染学杂志,2023,33(23):3552-3556.
ZHANG J,LI Y K,WANG Z,et al.Etiology of multi-drug resistant bacteria infection in severe pneumonia patients and the construction of influencing factors model[J].Chin J Nosocomiol,2023,33(23):3552-3556.(in Chinese)
[16] 何亚盛,张红霞,倪银,等.急诊重症监护病房住院患者医院感染的预测模型研究[J].预防医学,2022,34(9):919-922.
HE Y S,ZHANG H X,NI Y,et al.A model to predict nosocomial infections among inpatients in emergency intensive care units[J].China Prev Med J,2022,34(9):919-922.(in Chinese)
[17] BABA Y,ISHIGURO T,GOCHI M,et al.A 72-year-old woman with respiratory failure and bilateral ground-glass opacities[J].Chest,2020,158(1):41-45.
[18] 林芳,刘素贞,江海燕.老年2型糖尿病患者营养不良的影响因素分析[J].预防医学,2024,36(1):61-64,69.
LIN F,LIU S Z,JIANG H Y.Factors affecting malnutrition among elderly patients with type 2 diabetes mellitus[J].China Prev Med J,2024,36(1):61-64,69.(in Chinese)
[1] 吴成慧, 彭艳红, 张可, 朱维晔, 邓亮, 谭玲玲, 瞿丹丹, 米秋香. 中青年2型糖尿病患者益处发现的影响因素分析[J]. 预防医学, 2026, 38(1): 31-35.
[2] 徐光明, 张震, 叶小红. 2015—2024年临海市新报告HIV/AIDS病例晚发现及影响因素分析[J]. 预防医学, 2026, 38(1): 71-74.
[3] 夏子淇, 陈晴晴, 高四海, 吴矛矛. 温州市中小学生营养健康知识调查[J]. 预防医学, 2026, 38(1): 98-101,106.
[4] 陈慧, 苗姗姗, 刘宪峰, 张慧. 新疆生产建设兵团中小学生龋齿现况调查[J]. 预防医学, 2026, 38(1): 102-106.
[5] 吕婧, 徐欣颖, 乔颖异, 石兴龙, 岳芳, 刘营, 程传龙, 张宇琦, 孙继民, 李秀君. 浙江省发热伴血小板减少综合征流行特征及影响因素分析[J]. 预防医学, 2026, 38(1): 10-14.
[6] 陶桃, 张海芳, 凡鹏飞, 李秋华, 陈晓蕾. 丽水市老年肺结核患者治疗转归的影响因素分析[J]. 预防医学, 2025, 37(9): 892-896,902.
[7] 徐艳平, 闫晓彤, 姚丁铭, 徐越, 张雪海, 孙洁, 徐锦杭. 浙江省中老年人肺炎疫苗接种意愿的影响因素研究[J]. 预防医学, 2025, 37(9): 881-885.
[8] 姜艳, 李锦成, 许纯, 杨科佼, 杨文彬, 徐胜. 扬州市MSM人群艾滋病非职业暴露后预防知晓率调查[J]. 预防医学, 2025, 37(9): 903-906,912.
[9] 翟羽佳, 章涛, 古雪, 徐乐, 吴梦娜, 林君芬, 吴晨. 社区老年人认知衰弱现况调查[J]. 预防医学, 2025, 37(8): 762-766,772.
[10] 苏德华, 陈向阳, 李君, 赵丽娜, 张鹤美, 朱婷婷, 胡文雪, 赖江宜. 温州市新报告HIV/AIDS病例抗病毒治疗及时性分析[J]. 预防医学, 2025, 37(8): 804-808.
[11] 严青秀, 王炜, 郝晓刚, 高宇, 方春福, 张幸, 刘文峰. 2017—2023年衢州市肺结核患者未收治情况分析[J]. 预防医学, 2025, 37(8): 799-803.
[12] 王晓宇, 张志平, 董玉颖, 梁杰, 陈强. 老年人带状疱疹疫苗接种意愿的影响因素分析[J]. 预防医学, 2025, 37(8): 809-813.
[13] 王海琪, 张涵潇, 杨凤云, 国献丽, 范生荣, 张丽锋, 蒋泓. 嘉定区中学生抑郁情绪调查[J]. 预防医学, 2025, 37(8): 832-836.
[14] 成灵灵, 阎亚琼, 白增华, 张晓刚, 郝丽婷, 杨慧莹. 先天性甲状腺功能减退症患儿年龄别体质指数Z评分变化轨迹及影响因素[J]. 预防医学, 2025, 37(8): 858-863.
[15] 陈强, 郭震, 朱玮, 何晓庆, 朱斌斌. 金华市重点人群职业健康素养调查[J]. 预防医学, 2025, 37(7): 747-750,756.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed